COVID-19 Pill | The Salesmark
Merck’s COVID Pill Progress Sparks Asian Vaccine Stock Selloff

Merck’s COVID Pill Progress Sparks Asian Vaccine Stock Selloff

The results of the study on Merck’s pill were so encouraging that the drugmaker and its partner, in consultation with independent trial monitors and the U.S. Food and Drug Administration, elected to stop enrolling patients and begin the process of gaining regulatory clearance.